Federico Grossi - Nov 1, 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Chief Medical Officer
Signature
/s/ David Watson, attorney-in-fact for Federico Grossi
Stock symbol
APLS
Transactions as of
Nov 1, 2022
Transactions value $
-$152,075
Form type
4
Date filed
11/3/2022, 04:27 PM
Previous filing
Oct 5, 2022
Next filing
Dec 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale -$152K -2.5K -2.44% $60.83 99.9K Nov 1, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected by pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 25, 2022.